Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Anna, Lligoña"'
Autor:
Elsa Caballeria, Mercè Balcells-Oliveró, Ramón Bataller, Pol Bruguera, Noel Cabrera, Alexandra Estruch, Neus Freixa, Óscar Garcia-Pañella, Mireia Graell, Jordi Gratacós-Gines, Pablo Guzman, Anna Hernández-Rubio, Anna Lligoña, Martina Pérez-Guasch, María Teresa Pons-Cabrera, Elisa Pose, Paola Zuluaga, Hugo López-Pelayo
Publikováno v:
Digital Health, Vol 10 (2024)
Background With the aim of improving treatment retention in patients with the onset of alcohol-related liver disease (ArLD), we designed a blended intervention (brief motivational intervention + ‘serious game’ (SG)). We present the participatory
Externí odkaz:
https://doaj.org/article/e0832bf6a1c645808d2df4bf58b43592
Autor:
Ana Isabel López-Lazcano, Hugo López-Pelayo, Antoni Gual, Anna Lligoña, Vanessa Vilas-Riotorto, Elsa Caballeria, Pol Bruguera, Luis Pintor
Publikováno v:
Transplantology, Vol 2, Iss 1, Pp 64-74 (2021)
Health-related quality of life (HRQOL) before and after liver transplant (LT) is an important outcome in LT candidates as, in these patients, HRQOL is commonly impaired. However, evidence regarding factors that influence HRQOL in patients with end-st
Externí odkaz:
https://doaj.org/article/9a4f3881a25d4dcb8fe3412a15b1613a
Autor:
Miquel, Monras, Laura, Nuño, Ana, López-Lazcano, Clara, Escribano-Sáiz, Queralt, Del Valle, Anna, Lligoña
Publikováno v:
Adicciones.
The Covid19 pandemic has led to many publications about its influence on the treatment and evolution of individuals with a substance use disorder, leading to contradictory results. In this study, the adherence and abstinence rates of patients who sta
Autor:
Miquel Monras, Laura Nuño, Ana Lopez-Lazcano, Clara Escribano-Saiz, Queralt Del Valle, Anna Lligoña
Publikováno v:
Adicciones.
Autor:
Beltrán, Jiménez-Fernández, Cristina, Calomarde-Gómez, Ana, López-Lazcano, Anna, Lligoña, Antoni, Gual, Hugo, López-Pelayo
Publikováno v:
Adicciones.
The crisis caused by prescribed opioids and their related side effects are a public health problem worldwide. Most of these are prescribed for coping with chronic pain. The coexistence of opioid use disorder (OUD) in patients with chronic pain repres
Autor:
Beltrán Jiménez-Fernández, Cristina Calomarde-Gómez, Ana López-Lazcano, Anna Lligoña, Antoni Gual, Hugo López-Pelayo
Publikováno v:
Adicciones.
Autor:
José Altamirano, Ramón Bataller, Andres Cardenas, Javier Michelena, Neus Freixa, Miquel Monrás, José Ríos, Alexandre Liccioni, Juan Caballería, Antoni Gual, Anna Lligoña, M.D.
Publikováno v:
Annals of Hepatology, Vol 11, Iss 2, Pp 213-221 (2012)
Introduction. Alcoholic cirrhosis is one of the most common indications for liver transplantation (LT) in western countries. A major concern about transplant patients due to alcoholic liver disease (ALD) is alcoholic recidivism. Data concerning psych
Externí odkaz:
https://doaj.org/article/fb46a52afca44c5db0300fd9f069deff
Autor:
Moisés Diago, Manuel Hernández-Guerra, Agustín Albillos, Rafael Bañares, Esther Molina, María Teresa Arias-Loste, Pere Ginès, Manuel Romero-Gómez, María Jesús Pareja, Joaquín Cabezas, Anna Lligoña, Santiago Tomé, Rocío Gallego, Javier Abad, Joan Genescà, Ramon Bataller, Juan Caballería, Ramon Planas, Rocío Aller, Javier Salmerón, F. Jorquera, José A. Carrión, José Altamirano, Carmelo García-Monzón, Meritxell Ventura-Cots, Miren García-Cortés, Conrado M Fernández Rodríguez, Llorenç Caballería
Publikováno v:
Gastroenterología y Hepatología. 42:657-676
Alcohol-related liver disease (ARLD) is the most prevalent cause of advanced liver disease and liver cirrhosis in Europe, including Spain. According to the World Health Organization the fraction of liver cirrhosis attributable to alcohol use in Spain
Autor:
Miquel Navasa, Ana M. López, Jordi Colmenero, Antoni Gual, E. López, Julissa Lombardo-Quezada, Anna Lligoña, Hugo López-Pelayo, Carolina Gavotti, Gonzalo Crespo
Publikováno v:
Liver Transplantation. 25:1142-1154
The selection of liver transplantation (LT) candidates with alcohol-use disorder (AUD) is influenced by the risk of alcohol relapse (AR) after LT. We aimed to investigate the risk factors of AR after LT and its impact on graft and recipient outcomes.
Autor:
Antoni Gual, Joan Caballería, José Altamirano, Ramon Bataller, Laia Miquel, Hugo López-Pelayo, Anna Lligoña, Lluisa Ortega
Publikováno v:
Recercat. Dipósit de la Recerca de Catalunya
instname
Dipòsit Digital de la UB
Universidad de Barcelona
instname
Dipòsit Digital de la UB
Universidad de Barcelona
Aims Alcoholic hepatitis (AH) is a life-threatening complication of alcohol use disorder (AUD). Alcohol abstinence is the main predictor of the long-term prognosis of AH. It is unknown whether AUD treatment retention (TR) after an AH episode impacts